Skip to main content
padlock icon - secure page this page is secure

Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia

Buy Article:

$59.00 + tax (Refund Policy)

Risk of thrombosis is significantly enhanced by both elevated platelet (PLT) and white blood cell (WBC) counts according to a retrospective analysis of a large anagrelide registry in thrombocythemic MPN patients. We were interested in the impact of elevated WBC counts on thrombosis risk in patients where PLT counts were reduced below the calculated cutoff of 574.5 G/L by treatment with anagrelide.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: essential thrombocythemia; thrombotic risk; white blood cells

Document Type: Research Article

Publication date: August 1, 2018

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more